Considering the impact of tumor vascularization and hypoxia, eg, on chemo- and radioresistance of tumors, targeted theranostics of functional EphB4 is suspected to contribute to early detection of high risk groups and to personally improve patients’ prognosis and therapy outcome, which are the major principles of melanoma control [96]. The gene discussed is EPHB4; the disease is neoplasm.